Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Other Operating Expenses (2016 - 2025)

Ocular Therapeutix (OCUL) has 13 years of Other Operating Expenses data on record, last reported at $14.6 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 20.56% year-over-year to $14.6 million; the TTM value through Dec 2025 reached $60.5 million, up 28.13%, while the annual FY2025 figure was $60.5 million, 28.13% up from the prior year.
  • Other Operating Expenses reached $14.6 million in Q4 2025 per OCUL's latest filing, down from $14.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $15.7 million in Q2 2025 and bottomed at $9.0 million in Q1 2021.
  • Average Other Operating Expenses over 5 years is $11.9 million, with a median of $11.5 million recorded in 2024.
  • Peak YoY movement for Other Operating Expenses: soared 56.18% in 2021, then dropped 7.9% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $10.2 million in 2021, then rose by 12.69% to $11.5 million in 2022, then decreased by 7.9% to $10.6 million in 2023, then increased by 13.53% to $12.1 million in 2024, then grew by 20.56% to $14.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $14.6 million in Q4 2025, $14.9 million in Q3 2025, and $15.7 million in Q2 2025.